Management of CLN1 Disease: International Clinical Consensus

Keyphrases

• Clinical Consensus 100%
• CLN1 Disease 100%
• Caregivers 50%
• Clinical Prognosis 16%
• Seizure 16%
• Clinical Practice Guidelines 16%
• Clinical Features 16%
• Age of Onset 16%
• Ataxia 16%
• Rare Diseases 16%
• Clinical Practice 16%
• Visual Impairment 16%
• Clinical Care 16%
• Neurodegeneration 16%
• Clinical Course 16%
• Disease Course 16%
• Lysosomal Storage Disease 16%
• Adult-onset 16%
• Movement Disorders 16%
• Current Needs 16%
• Early Death 16%
• Care Needs 16%
• Developmental Delay 16%
• Enzyme Deficiency 16%
• Disease Phenotype 16%
• Consensus Recommendations 16%
• Management Recommendations 16%
• Neuronal Ceroid Lipofuscinosis 16%
• Clinical Practice Recommendations 16%
• Family Quality of Life 16%
• Psychomotor Regression 16%
• Family Perspectives 16%
• Expert Practice 16%
• Late Infantile 16%
• Family-centered Approach 16%
• Lack of Evidence 16%
• Multidisciplinary Care 16%
• Patient Quality of Life 16%
• Juvenile-onset 16%
• Palmitoyl-protein Thioesterase 1 16%

Medicine and Dentistry

• Diseases 100%
• Disease Course 33%
• Epileptic Seizure 16%
• Clinician 16%
• Base 16%
• Clinical Feature 16%
• Quality of Life 16%
• Ataxia 16%
• Rare Disease 16%
• Visual Impairment 16%
• Clinical Management 16%
• Storage Disease 16%
• Lysosomal Storage Disease 16%
• Developmental Delay 16%
• Stereotypic Movement Disorder 16%
• Resuscitation 16%
• Enzyme Deficiency 16%
• Palmitoyl Protein Thioesterase 16%
• Batten Disease 16%
• Genetics 16%